- Home
- ATYR vs MRT Comparison
ATYR vs MRT Comparison
Compare ATYR & MRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- MRT
- Stock Information
- Founded
- ATYR 2005
- MRT 2018
- Country
- ATYR United States
- MRT Turkey
- Employees
- ATYR N/A
- MRT N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- MRT Rental/Leasing Companies
- Sector
- ATYR Health Care
- MRT Consumer Discretionary
- Exchange
- ATYR Nasdaq
- MRT Nasdaq
- Market Cap
- ATYR 126.3M
- MRT 117.0M
- IPO Year
- ATYR 2015
- MRT N/A
- Fundamental
- Price
- ATYR $2.24
- MRT $2.08
- Analyst Decision
- ATYR Strong Buy
- MRT Buy
- Analyst Count
- ATYR 4
- MRT 1
- Target Price
- ATYR $19.25
- MRT $0.90
- AVG Volume (30 Days)
- ATYR 578.6K
- MRT 48.1K
- Earning Date
- ATYR 11-07-2024
- MRT 01-01-0001
- Dividend Yield
- ATYR N/A
- MRT N/A
- EPS Growth
- ATYR N/A
- MRT N/A
- EPS
- ATYR N/A
- MRT N/A
- Revenue
- ATYR $588,000.00
- MRT $18,953,502.00
- Revenue This Year
- ATYR N/A
- MRT N/A
- Revenue Next Year
- ATYR $2,057.88
- MRT N/A
- P/E Ratio
- ATYR N/A
- MRT N/A
- Revenue Growth
- ATYR N/A
- MRT N/A
- 52 Week Low
- ATYR $1.08
- MRT $0.44
- 52 Week High
- ATYR $2.50
- MRT $2.73
- Technical
- Relative Strength Index (RSI)
- ATYR 74.73
- MRT 54.90
- Support Level
- ATYR $1.83
- MRT $1.97
- Resistance Level
- ATYR $1.96
- MRT $2.13
- Average True Range (ATR)
- ATYR 0.10
- MRT 0.11
- MACD
- ATYR 0.05
- MRT 0.02
- Stochastic Oscillator
- ATYR 90.48
- MRT 86.78
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About MRT Marti Technologies Inc.
Marti Technologies Inc is a mobility app, operating a fleet of over 48,000 e-mopeds, e-bikes, and e-scooters, serviced by proprietary software systems and IoT infrastructure.